Healthcare companies by risk reading
Healthcare companies by risk reading: 1,214 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 1 September 2026.
Composite readings for 8,308 companies, recomputed 1 September 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Oncodesign Precision Medicine ALOPM | 41 | Elevated | Healthcare | France | 3 / 6 | $7M |
| GENINCODE PLC LS -01 9PL | 31 | Normal | Healthcare | United Kingdom | 5 / 6 | $7M |
| Biomerica Inc BMRA | 52 | Elevated | Healthcare | United States | 5 / 6 | $6M |
| Cambridge Nutritional Sciences plc CNSL | 38 | Normal | Healthcare | United Kingdom | 5 / 6 | $6M |
| Immuron Ltd IMRN | 24 | Normal | Healthcare | Australia | 4 / 6 | $6M |
| Sonoma Pharmaceuticals Inc SNOA | 31 | Normal | Healthcare | United States | 5 / 6 | $6M |
| SCWorx Corp WORX | 45 | Elevated | Healthcare | United States | 4 / 6 | $6M |
| Gelteq Ltd GELS | 72 | Stretched | Healthcare | Australia | 3 / 6 | $6M |
| Aclarion Inc ACON | 62 | Stretched | Healthcare | United States | 4 / 6 | $6M |
| Ensysce Biosciences Inc ENSC | 35 | Normal | Healthcare | United States | 5 / 6 | $6M |
| Innovative Eyewear Inc LUCY | 54 | Elevated | Healthcare | United States | 4 / 6 | $6M |
| OMEGA DIAGNOST.GR. LS-04 RVKA | 39 | Normal | Healthcare | United Kingdom | 5 / 6 | $6M |
| Lifecare ASA LFC0 | 81 | Acute | Healthcare | Norway | 3 / 6 | $6M |
| Plant Advanced Technologies SA ALPAT | 46 | Elevated | Healthcare | France | 4 / 6 | $6M |
| CollPlant Biotechnologies Ltd New CLGN | 39 | Normal | Healthcare | Israel | 5 / 6 | $6M |
| Cardio Diagnostics Holdings Inc CDIO | 59 | Elevated | Healthcare | United States | 5 / 6 | $6M |
| Bluelinea SA ALBLU | 48 | Elevated | Healthcare | France | 5 / 6 | $5M |
| Spineway ALSPW | 25 | Normal | Healthcare | France | 4 / 6 | $5M |
| N4 Pharma PLC N4P | 47 | Elevated | Healthcare | United Kingdom | 3 / 6 | $5M |
| SynBiotic SE SBX | 34 | Normal | Healthcare | Germany | 5 / 6 | $5M |
| BioRestorative Therapies Inc BRTX | 56 | Elevated | Healthcare | United States | 4 / 6 | $5M |
| cbdMD Inc YCBD | 46 | Elevated | Healthcare | United States | 5 / 6 | $5M |
| Spineway SA 37S | 25 | Normal | Healthcare | France | 4 / 6 | $5M |
| Predilife ALPRE | 55 | Elevated | Healthcare | France | 5 / 6 | $5M |
| BioXcel Therapeutics Inc BTAI | 56 | Elevated | Healthcare | United States | 5 / 6 | $5M |
| Addex Therapeutics Ltd ADXN | 75 | Stretched | Healthcare | Switzerland | 4 / 6 | $5M |
| Proteome Sciences plc PI2 | 69 | Stretched | Healthcare | United Kingdom | 5 / 6 | $5M |
| Moolec Science SA MLEC | 58 | Elevated | Healthcare | Cayman Islands | 5 / 6 | $5M |
| Intelligent Bio Solutions Inc INBS | 69 | Stretched | Healthcare | United States | 4 / 6 | $5M |
| CASI Pharmaceuticals Inc CASI | 69 | Stretched | Healthcare | China | 5 / 6 | $5M |
| Zelira Therapeutics Ltd ZLD | 83 | Acute | Healthcare | Australia | 4 / 6 | $5M |
| Immuron Limited ANW | 24 | Normal | Healthcare | Australia | 4 / 6 | $5M |
| Redhill Biopharma Ltd RDHL | 79 | Stretched | Healthcare | Israel | 4 / 6 | $5M |
| Geovax Labs Inc GOVX | 49 | Elevated | Healthcare | United States | 5 / 6 | $5M |
| InMed Pharmaceuticals Inc INM | 26 | Normal | Healthcare | Canada | 4 / 6 | $4M |
| Pheton Holdings Ltd - Class A ITOC | 77 | Stretched | Healthcare | China | 5 / 6 | $4M |
| Creative Medical Technology Holdings Inc CELZ | 80 | Acute | Healthcare | United States | 3 / 6 | $4M |
| Can-Fite Biopharma Ltd CANF | 76 | Stretched | Healthcare | Israel | 5 / 6 | $4M |
| Alaunos Therapeutics Inc TCRT | 83 | Acute | Healthcare | United States | 4 / 6 | $4M |
| Feedback PLC FDBK | 72 | Stretched | Healthcare | United Kingdom | 4 / 6 | $4M |
| HITIQ Ltd HIQ | 76 | Stretched | Healthcare | Australia | 4 / 6 | $4M |
| HCW Biologics Inc HCWB | 80 | Acute | Healthcare | United States | 4 / 6 | $4M |
| VERICI DX PLC LS-001 63V | 60 | Stretched | Healthcare | United Kingdom | 4 / 6 | $4M |
| SciSparc Ltd SPRC | 72 | Stretched | Healthcare | Israel | 4 / 6 | $4M |
| VolitionRX Ltd VNRX | 52 | Elevated | Healthcare | United States | 5 / 6 | $3M |
| Zhongchao Inc - Class A ZCMD | 51 | Elevated | Healthcare | China | 5 / 6 | $3M |
| Nexgel Inc NXGL | 41 | Elevated | Healthcare | United States | 5 / 6 | $3M |
| Sanai Health Industry Group Company Limited WUP0 | 60 | Stretched | Healthcare | Hong Kong | 5 / 6 | $3M |
| Monsenso AS MONSO | 44 | Elevated | Healthcare | Denmark | 5 / 6 | $3M |
| Physiomics Plc PYC | 42 | Elevated | Healthcare | United Kingdom | 4 / 6 | $3M |
| Futura Medical FUM | 89 | Acute | Healthcare | United Kingdom | 3 / 6 | $3M |
| 60 Degrees Pharmaceuticals Inc SXTP | 45 | Elevated | Healthcare | United States | 5 / 6 | $3M |
| BioAtla Inc BCAB | 68 | Stretched | Healthcare | United States | 5 / 6 | $3M |
| Vivos Therapeutics Inc VVOS | 59 | Elevated | Healthcare | United States | 5 / 6 | $3M |
| Universe Pharmaceuticals Inc UPC | 52 | Elevated | Healthcare | China | 5 / 6 | $3M |
| Prostatype Genomics AB PROGEN | 67 | Stretched | Healthcare | Sweden | 4 / 6 | $3M |
| OXFORD BIODYNAMICS LS-01 LMQ | 61 | Stretched | Healthcare | United Kingdom | 5 / 6 | $2M |
| PHYSIOMICS PLC LS -004 RVW1 | 46 | Elevated | Healthcare | United Kingdom | 4 / 6 | $2M |
| Mainz Biomed N.V. MYNZ | 55 | Elevated | Healthcare | Germany | 5 / 6 | $2M |
| Phaos Technology (Cayman) Holdings Ltd - Class A POAS | 96 | Acute | Healthcare | Singapore | 4 / 6 | $2M |
| Beyond Air Inc XAIR | 72 | Stretched | Healthcare | United States | 5 / 6 | $2M |
| Osteopore Ltd OSX | 33 | Normal | Healthcare | Singapore | 4 / 6 | $2M |
| China SXT Pharmaceuticals Inc SXTC | 84 | Acute | Healthcare | China | 5 / 6 | $2M |
| Akanda Corp AKAN | 98 | Acute | Healthcare | Canada | 4 / 6 | $2M |
| Alligator Bioscience AB ATORX | 60 | Stretched | Healthcare | Sweden | 3 / 6 | $2M |
| Anatara Lifesciences Ltd ANR | 31 | Normal | Healthcare | Australia | 3 / 6 | $2M |
| Argent BioPharma Limited H5O0 | 85 | Acute | Healthcare | Australia | 4 / 6 | $2M |
| Prostatype Genomics AB (publ) PGO0 | 68 | Stretched | Healthcare | Sweden | 4 / 6 | $2M |
| Sunshine Biopharma Inc SBFM | 32 | Normal | Healthcare | United States | 5 / 6 | $2M |
| Jupiter Neurosciences Inc JUNS | 82 | Acute | Healthcare | United States | 3 / 6 | $2M |
| Bonyf NV MLBON | 66 | Stretched | Healthcare | Belgium | 3 / 6 | $2M |
| Oakridge International Ltd OAK | 11 | Contained | Healthcare | Australia | 4 / 6 | $2M |
| INVO Fertility Inc IVF | 45 | Elevated | Healthcare | United States | 4 / 6 | $2M |
| Healthcare Triangle Inc HCTI | 67 | Stretched | Healthcare | United States | 5 / 6 | $2M |
| ACRUX LTD. FJY | 76 | Stretched | Healthcare | Australia | 4 / 6 | $1M |
| CHINA HEALTH GRP HD-10 VNL1 | 16 | Contained | Healthcare | China | 4 / 6 | $1M |
| Elixinol Wellness Limited E8M | 32 | Normal | Healthcare | Australia | 4 / 6 | $1M |
| iSpecimen Inc ISPC | 89 | Acute | Healthcare | United States | 4 / 6 | $1M |
| AVALA RES CVJ | 36 | Normal | Healthcare | Australia | 4 / 6 | $962,314 |
| Ridgetech Inc RDGT | 39 | Normal | Healthcare | China | 5 / 6 | $844,966 |
| Lyra Therapeutics Inc LYRA | 84 | Acute | Healthcare | United States | 4 / 6 | $843,078 |
| VivoSim Labs Inc VIVS | 68 | Stretched | Healthcare | United States | 4 / 6 | $839,405 |
| VALIRX PLC LS-001 EAJF | 70 | Stretched | Healthcare | United Kingdom | 5 / 6 | $765,115 |
| PRF Technologies Ltd PRFX | 65 | Stretched | Healthcare | Israel | 4 / 6 | $747,077 |
| VSee Health Inc VSEE | 24 | Normal | Healthcare | United States | 4 / 6 | $728,991 |
| Onconetix Inc ONCO | 88 | Acute | Healthcare | United States | 3 / 6 | $718,856 |
| Trellus Health plc TRLS | 57 | Elevated | Healthcare | United States | 4 / 6 | $698,394 |
| S2Medical AB S2M | 23 | Normal | Healthcare | Sweden | 3 / 6 | $651,404 |
| Scorpius Holdings Inc SCPX | 65 | Stretched | Healthcare | United States | 5 / 6 | $611,427 |
| Catheter Precision Inc VTAK | 78 | Stretched | Healthcare | United States | 4 / 6 | $538,500 |
| Oxurion NV OXUR | 77 | Stretched | Healthcare | Belgium | 3 / 6 | $424,091 |
| Inotiv Inc NOTV | 57 | Elevated | Healthcare | United States | 4 / 6 | $418,657 |
| CO.DON AG INH. O.N. CNW | 90 | Acute | Healthcare | Germany | 3 / 6 | $418,127 |
| Jaguar Health Inc JAGX | 80 | Acute | Healthcare | United States | 5 / 6 | $294,252 |
| NewGenIvf Group Ltd - Class A NIVF | 71 | Stretched | Healthcare | Thailand | 5 / 6 | $255,825 |
| TRELLUS HEALTH LS -0006 85Q | 58 | Elevated | Healthcare | United States | 4 / 6 | $249,254 |
| Safe Orthopaedics SA ALSAF | 46 | Elevated | Healthcare | France | 5 / 6 | $147,789 |
| IQ-AI LTD. LS -01 5Y1 | 26 | Normal | Healthcare | Jersey | 4 / 6 | $142,968 |
| OR9 OR9 | 47 | Elevated | Healthcare | France | 5 / 6 | $113,151 |
| 7AL0 7AL0 | 61 | Stretched | Healthcare | Sweden | 3 / 6 | $72,798 |
By sector
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.